Search results

  1. MSEsperanza

    Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post–COVID-19 Condition, 2023, Liu et al

    Science Media Centre's (UK) take on this: Dr Michael Zandi, Consultant Neurologist, UCL, said: “The authors present a study looking at factors that go hand in hand with memory and other cognitive symptoms after Covid, and show that these symptoms are common and can predict the development of...
  2. MSEsperanza

    UK:ME Association funds research for a new clinical assessment toolkit in NHS ME/CFS specialist services, 2023

    Apologies, off topic but find it hard to cope with the fact that a number of forum members much smarter than I and who started or were engaged in related discussions have died or are too sick now so can't engage in a discussion anymore. Perhaps we could find a way to manage the discussion in a...
  3. MSEsperanza

    UK:ME Association funds research for a new clinical assessment toolkit in NHS ME/CFS specialist services, 2023

    Could you give examples? I don't get why you need psychometric measurement tools for monitoring patients with ME/CFS. I think a smart symptoms/ activity diary could be helpful if doesn't need too much time to fill in? Also with regard to wearables, I agree they have to be validated / adjusted...
  4. MSEsperanza

    UK:ME Association funds research for a new clinical assessment toolkit in NHS ME/CFS specialist services, 2023

    Maybe a difference is that talking about RA symptom and coping with the disease and treatments is not as 'complex' as talking about ME/CFS symptoms and coping. Talking about PEM is difficult as is talking about coping/ pacing -- just recalling and giving an account of all the things that...
  5. MSEsperanza

    Basic questions on terms and methodology used in clinical trials

    Related to the discussion on developing assessment tools for monitoring disease activity/ impact/ disability -- Why is the term 'psychometric' used for scales that measure also physical symptoms / symptom burden / disability? Is a simple visual analog pain rating scale or a symptom diary also...
  6. MSEsperanza

    Evaluating the ability of patient reported outcome measures to represent the functional limitation of people living with ME/CFS, 2023, Jones, Gladwell

    Apologies, only read the abstract and thought the paper's main finding was that not all reductions in functioning relevant to people with ME/CFS are covered by the International Classification of Functioning, Disability and Health (ICF) [edit: and other scales/ questionnaires commonly used by...
  7. MSEsperanza

    UK:ME Association funds research for a new clinical assessment toolkit in NHS ME/CFS specialist services, 2023

    Hi @sarahtyson & welcome to the forum. Great to have you -- as an expert who's also a person with ME/CFS and a carer -- on the forum engaging with this important discussion. Not able to add much now but you might be interested in previous discussions on the forum -- we have several threads on...
  8. MSEsperanza

    Bias due to a lack of blinding: a discussion

    This paper posted on a thread of its own might be a useful addition to the discussion (not related to ME/CFS) ?
  9. MSEsperanza

    The difficulties of conducting intervention trials for the treatment of [ME/CFS]: Expert testimony to NICE guidelines committee by Jonathan Edwards

    Recently was reminded that there's a translation of Jo's testimony into German. Translation was commissioned by the German charity Fatigatio -- here's the link: https://www.fatigatio.de/fileadmin/Projects/07_fatigatio/user_upload/PDFs/PDFs_Sonstige/NICE_Kommentar_Prof_Edwards.pdf Thank you...
  10. MSEsperanza

    Bias due to a lack of blinding: a discussion

    Don't think it was redundant. Also, still hope I or anyone else will be able someday to a) find people who could (help) translate it into German, b) to get -- with the help of your testimony and the paper by Tack et al -- other patient communities / umbrella organizations interested in the...
  11. MSEsperanza

    ME Awareness Day / Week / Month, May 2023

    Anil van der Zee on Twitter: "A short blog post for M.E. Awareness Month for the #MillionsMissing Missing." https://t.co/fYldgZODZI
  12. MSEsperanza

    UK NICE 2021 ME/CFS Guideline, published 29th October - post-publication discussion

    Apologies for cross-posting from another thread: This year's Conference of the European Association of Psychosomatic Medicine (EAPM) in June 2023 in Wrocław (Poland) will dedicate a 'symposium' to the new Guideline: https://www.eapm-conference.org/index.php/program/main-program FRIDAY 16 |...
  13. MSEsperanza

    European Research Network to Improve Diagnosis, Treatment and Health Care for Patients with Persistent Somatic Symptoms (EURONET-SOMA)

    Thanks for posting -- did not see this one: FRIDAY 16 | 10:15-11:30 | KAMIENICA ROOM SYMPOSIUM CFS/ME: CONTROVERSY AND COMMUNICATION FOLLOWING THE 2022 UK NICE GUIDELINES CHAIR Per Fink. Research Clinic for Functional disorders and Psychosomatics, Aarhus University Hospital. Denmark What is...
  14. MSEsperanza

    European Research Network to Improve Diagnosis, Treatment and Health Care for Patients with Persistent Somatic Symptoms (EURONET-SOMA)

    "The EURONET-SOMA networks meets regularly twice a year: a brief meeting takes place during the annual conference of the European Association of Psychosomatic Medicine (EAPM). This meeting is open to all attendees of the EAPM conference. The second, more extensive meeting takes place in autumn...
  15. MSEsperanza

    A general thread on the PACE trial!

    A recent reference to the PACE trial in a study protocol (*) by one of the project teams of the large SOMA.CROSS research group at the UKE Hamburg: "Integrated biopsychosocial research in patients with multiple sclerosis (MS) and poststroke found a fatigue-enhancing cycle of avoidance behaviour...
  16. MSEsperanza

    Persistent SOMAtic symptoms ACROSS diseases [SOMACROSS]—from risk factors to modification: scientific framework & overarching protocol, 2022

    Have to resume my forum break now but I think it would be worthwhile to post the protocols of this research group's individual projects too. So if anyone felt up to it, they are here. Couldn't find the protocol for the Long Covid sub-project though. I think a critique of that project is...
  17. MSEsperanza

    Persistent SOMAtic symptoms ACROSS diseases [SOMACROSS]—from risk factors to modification: scientific framework & overarching protocol, 2022

    This is the 'umbrella' protocol for the individual projects of SOMACROSS which is 'inspired' by EURONET-SOMA see this thread. Biomedical clinician scientists are also on that ship as principal investigators, e.g. in the research groups on irritable bowel syndrome and ulcerative colitis...
  18. MSEsperanza

    News from Austria and Switzerland

    Direct link to the text (html) here. Website: https://www.parlament.gv.at/gegenstand/XXVII/I/2009 -> "Dokumente" -> "Entschließungstext"
  19. MSEsperanza

    European Research Network to Improve Diagnosis, Treatment and Health Care for Patients with Persistent Somatic Symptoms (EURONET-SOMA)

    Scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211) BMJ Open 2022;12:e057596. doi: 10.1136/bmjopen-2021-057596 Posted on an own thread.
Back
Top Bottom